EGFR agonist (Allelix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEGFR agonist (Allelix)
Drug Alias Nameepidermal growth factor receptor agonist(Allelix)epidermal growth factorPEG-epidermal growth factorEGF
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsWounds and InjuriesEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNps Allelix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNps Allelix Corp
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A